"In the fourth quarter of 2025, we again delivered strong financial results, including a new record of Annual Contract Value plus royalties reaching $83.6 million, representing 28% year-over-year growth. During the quarter, our customers surpassed the milestone of more than four billion systems shipped with SoCs connected by Arteris System IP, and we enjoyed royalty growth of 50% year-over-year," said K. Charles Janac, President and CEO of Arteris. "As cybersecurity threats intensify not just in software but the underlying hardware used across data centers, edge devices, and mission-critical systems, our recent acquisition of Cycuity strengthens Arteris' ability to help customers secure data movement in silicon through proven technology and deep domain expertise. Combined with the acceleration of AI use in semiconductors and the ever increasing SoC complexities created by the proliferation of chiplet-based, multi-die architectures, Arteris is well positioned to deliver on these transformative opportunities," concluded Janac.
Fourth Quarter 2025 Financial Highlights:
Revenue of $20.1 million, up 30% year-over-year
Annual Contract Value (ACV) plus royalties of $83.6 million, up 28% year-over-year, growing to the highest level we have ever reported
Remaining performance obligation (RPO) of $116.8 million, up 32% year-over-year, growing to the highest level we have ever reported. We expect approximately half of our RPO will be recognized as revenue in 2026. This projection excludes cancelable and non-cancelable Flexible Spending Accounts.
Operating loss of $8.5 million, compared to an operating loss of $7.1 million in the fourth quarter of 2024
Non-GAAP operating loss of $2.2 million, compared to a Non-GAAP operating loss of $2.8 million in the fourth quarter of 2024
Net loss of $8.5 million or $0.19 per share
Non-GAAP net loss of $2.3 million or $0.05 per share
Non-GAAP free cash flow of positive $3.0 million or 15% of revenue
Full year 2025 Financial Highlights:
Revenue of $70.6 million, up 22% year-over-year
Variable royalties of $6.6 million, up 50% year-over-year
Operating loss of $33.1 million, compared to an operating loss of $31.6 million for the year ended 2024
Non-GAAP operating loss of $12.5 million, compared to a Non-GAAP operating loss of $14.8 million for the year ended 2024
Net loss of $34.7 million or $0.82 per share
Non-GAAP net loss of $14.1 million or $0.33 per share
Non-GAAP free cash flow of positive $5.3 million or 8% of revenue
Recent Business Highlights:
In January 2026, we closed the acquisition of Cycuity, a leading provider of semiconductor security verification software. This acquisition strengthens Arteris' product portfolio, enabling customers to improve security in IP blocks, chiplets, SoCs and firmware;
Our customers have shipped over four billion SoC chips and chiplets incorporating Arteris network-on-chip technology as the underlying interconnect since Arteris' inception;
FlexGen smart NoC IP has seen strong customer adoption, ending the year with over 30 production device deployments by 10 different customers;
In February 2026, we announced NXP's expanded use of Arteris products across its AI enabled silicon solutions for intelligent vehicles, advanced industrial systems, and consumer electronics. This deployment includes Ncore cache coherent interconnect, FlexNoC non-coherent interconnect, CodaCache last-level cache IP, and Magillem software for SoC integration;
We announced that Black Sesame is licensing both Ncore and FlexNoC IP for its next-generation of advanced automotive semiconductors;
Blaize deployed FlexNoC IP for its Blaize AI platform, delivering a programmable, energy-efficient solution spanning edge and cloud-based AI; and
Arteris became a founding member of the CHASSIS program, an initiative led by Bosch and includes automotive OEMs such as BMW, Renault, and Stellantis, with the goal of creating an open automotive chiplet platform.
Non-GAAP gross profit, Non-GAAP gross margin, Non-GAAP operating loss, Non-GAAP net loss, Non-GAAP net loss per share, and free cash flow are Non-GAAP financial measures. Additional information on Arteris' historic reported results, including a reconciliation of these Non-GAAP financial measures to their most comparable GAAP measures, is included in the financial tables below.
Estimated First Quarter and Full Year 2026 Guidance:
Q1 2026
FY 2026
(in millions)
ACV + royalties
$85.0 - $89.0
$100.0 - $104.0
Revenue
$20.5 - $21.5
$89.0 - $93.0
Non-GAAP operating loss
$2.5 - $3.5
$5.0 - $9.0
Free cash flow
($1.5) - $1.5
$5.0 - $9.0
The guidance provided above are forward-looking statements and reflects Arteris' expectations as of today's date. Actual results may differ materially. Refer to the section titled "Forward-Looking Statements" below for information on the factors, among others, that could cause our actual results to differ materially from these forward-looking statements.
A reconciliation of Non-GAAP guidance measures reported above to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of expenses that may be incurred in the future, although it is important to note that these factors could be material to Arteris' results computed in accordance with GAAP.
Definitions of the other business metrics used in this press release including ACV, confirmed design starts and RPO are included below under the heading "Other Business Metrics."
Conference Call
Arteris will host a conference call today on February 12, 2026 to review its fourth quarter and full year 2025 financial results and to discuss its financial outlook.
Time:
4:30PM ET
United States/Canada Toll Free:
1-800-717-1738
International Toll:
1-646-307-1865
A live webcast will also be available in the Investor Relations section of Arteris' website at: https://ir.arteris.com/events-and-presentations
A replay of the webcast will be available in the Investor Relations section of Arteris' website approximately two hours after the conclusion of the call and remain available for approximately 30 calendar days.
About Arteris
Arteris is a leading provider of semiconductor technology that accelerates the creation of high-performance, power-efficient silicon with built-in safety, reliability, and security. Innovative Arteris products are designed to optimize data movement and help ease complexity in the modern AI era with network-on-chip (NoC) interconnect intellectual property (IP), system-on-chip (SoC) software for integration automation and hardware security assurance. All are used by the world's top technology companies to improve overall performance and engineering productivity, reduce risk, lower costs, and bring cutting-edge designs to market faster. Learn more at arteris.com.
© 2004-2026 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at https://www.arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.
Investor Contacts:ArterisNick HawkinsChief Financial Officer[email protected]
Sapphire Investor Relations, LLCErica Mannion and Michael Funari+1 617 542 6180[email protected]
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including but not limited to, statements regarding market trends and whether we are well positioned to capture these opportunities, our long-term growth opportunity and future financial and operating performance, including our GAAP and Non-GAAP estimated first quarter and full year 2026 guidance. The words such as "may," "will," "could," "expect," "approximately," "believe," "estimate," "future," "guidance," "outlook," and similar words or expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements contained herein are based on our historical performance and our current plans, estimates and expectations and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent our expectations as of the date of this press release. Subsequent events may cause these expectations to change, and we disclaim any obligation to update the forward-looking statements in the future, except as required by law. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from our current expectations. Important factors that could cause actual results to differ materially from those anticipated in our forward-looking statements include, but are not limited to, the significant competition we face from larger companies and third-party providers; our history of net losses; the amount of our future revenue recognition as it relates to our RPO as of December 31, 2025; whether semiconductor companies in the aerospace and defense market, automotive market, communications market, consumer electronics market, enterprise computing market, and industrial market incorporate our solutions into their end products and the growth and economic stability of these end markets; our ability to attract new customers and the extent to which our customers renew their subscriptions for our solutions; the ability of our customers' end products achieving market acceptance or growth; our ability to sustain or grow our licensing revenue; our ability, and the cost, to successfully execute on research and development efforts; the occurrence of product errors or defects in our solutions; if we fail to offer high-quality support; the occurrence of macro-economic conditions that adversely impact us, our customers and their end product markets including, but not limited to, the imposition of tariffs in markets where we operate; the effects of geopolitical conflicts, such as the military conflict between Russia and Ukraine as well as the ongoing conflict in the Middle East; the range of regulatory, operational, financial and political risks we are exposed to as a result of our dependence on international customers and operations; our ability to protect our proprietary technology and inventions through patents and other IP rights; whether we are subject to any liabilities or fines as a result of government regulation, including import, export and economic sanctions laws and regulations; the occurrence of a disruption in our networks or a security breach; risks associated with doing business in China, including as a result of changes to trade relations between the United States and China; and the other factors described under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025 to be filed with the Securities and Exchange Commission (SEC) on or about February 12, 2026. All forward-looking statements reflect our beliefs and assumptions only as of the date of this press release. We undertake no obligation to update forward-looking statements to reflect future events or circumstances. Our results for the quarter and year ended December 31, 2025 are not necessarily indicative of our operating results for any future periods.
Arteris, Inc.Condensed Consolidated Statements of Operations(In thousands, except share and per share data)(Unaudited)
Three Months EndedDecember 31,
Twelve Months EndedDecember 31,
2025
2024
2025
2024
Revenue
Licensing, support and maintenance
$
17,540
$
14,016
$
63,859
$
52,815
Variable royalties and other
2,597
1,473
6,720
4,909
Total revenue
20,137
15,489
70,579
57,724
Cost of revenue
1,861
1,575
6,895
5,962
Gross profit
18,276
13,914
63,684
51,762
Operating expenses:
Research and development
13,227
11,532
49,908
45,007
Sales and marketing
7,068
5,365
26,782
20,796
General and administrative
6,448
4,119
20,131
17,555
Total operating expenses
26,743
21,016
96,821
83,358
Loss from operations
(8,467
)
(7,102
)
(33,137
)
(31,596
)
Interest expense
(54
)
(45
)
(193
)
(244
)
Other income (expense), net
732
824
2,872
3,400
Loss before income taxes and loss from equity method investment
(7,789
)
(6,323
)
(30,458
)
(28,440
)
Loss from equity method investment, net of tax
734
634
2,813
2,698
Loss before income taxes
(8,523
)
(6,957
)
(33,271
)
(31,138
)
Provision for (benefit from) income taxes
(19
)
1,247
1,475
2,500
Net loss
$
(8,504
)
$
(8,204
)
$
(34,746
)
$
(33,638
)
Net loss per share attributable to common stockholders, basic and diluted
$
(0.19
)
$
(0.20
)
$
(0.82
)
$
(0.86
)
Weighted-average shares used in computing per share amounts, basic and diluted
43,710,109
40,157,199
42,290,619
38,914,197
Arteris, Inc.Condensed Consolidated Balance Sheets(In thousands, except share and per share data)
As of December 31,
2025
2024
ASSETS
Current assets:
Cash and cash equivalents
$
33,901
$
13,684
Short-term investments
20,698
30,157
Accounts receivable, net of allowance of $73 and $131 as of December 31, 2025, and 2024, respectively
19,183
20,608
Prepaid expenses and other current assets
8,608
